360 related articles for article (PubMed ID: 23628054)
1. [Clinical analysis of Epstein-Barr virus-associated hemophagocytic syndrome in children].
Guo X; Li Q; Zhou CY; Zhao YN
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Apr; 21(2):460-4. PubMed ID: 23628054
[TBL] [Abstract][Full Text] [Related]
2. [Clinical risk factors for Epstein-Barr virus-associated hemophagocytic syndrome in children with infectious mononucleosis].
Guo X; Li Q; Zhou CY; Zhao YN
Zhonghua Er Ke Za Zhi; 2008 Jan; 46(1):69-73. PubMed ID: 18353244
[TBL] [Abstract][Full Text] [Related]
3. [Clinical analysis and follow-up study of Epstein-Barr virus associated-hemophagocytic lymphohistiocytosis in childhood].
Lu G; Xie ZD; Shen KL; Wu RH; Jin YK; Yang S; Liu CY
Zhonghua Er Ke Za Zhi; 2010 Feb; 48(2):121-6. PubMed ID: 20426937
[TBL] [Abstract][Full Text] [Related]
4. [Clinical features and outcome analysis of 83 childhood Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis with HLH-2004 protocol].
Xiao L; Xian Y; Dai BT; Su YC; Xiao JW; Zheng QC; Zhao XD; Yu J
Zhonghua Xue Ye Xue Za Zhi; 2011 Oct; 32(10):668-72. PubMed ID: 22339824
[TBL] [Abstract][Full Text] [Related]
5. Hypoalbuminaemia is an independent predictor for hemophagocytic lymphohistiocytosis in childhood Epstein-Barr virus-associated infectious mononucleosis.
Huang SC; Chen JS; Cheng CN; Yang YJ
Eur J Haematol; 2012 Nov; 89(5):417-22. PubMed ID: 22897479
[TBL] [Abstract][Full Text] [Related]
6. Clinical warning of hemophagocytic syndrome caused by Epstein-Barr virus.
Shi J; Chu C; Yu M; Zhang D; Li Y; Fan Y; Yu Y; Luo Y; Zhou W
Ital J Pediatr; 2021 Jan; 47(1):3. PubMed ID: 33413556
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of Virology and Immune Inflammation of Epstein-Barr Virus Infection Related Non-Neoplastic Diseases in Children.
Wang Q; Duan Z; Duan W; Ruan M; Zhang Y; Zhang H; Zhou Q
Clin Lab; 2024 May; 70(5):. PubMed ID: 38747912
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics and laboratory findings in Danish children hospitalized with primary Epstein-Barr virus infection.
Topp SK; Rosenfeldt V; Vestergaard H; Christiansen CB; Von Linstow ML
Infect Dis (Lond); 2015; 47(12):908-14. PubMed ID: 26308113
[TBL] [Abstract][Full Text] [Related]
9. Comparative study of biomarkers for the early identification of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in infectious mononucleosis.
Cai L; Xing Y; Xia Y; Zhang Z; Luo Z; Tang Y; Chen Y; Xu X
BMC Infect Dis; 2023 Oct; 23(1):728. PubMed ID: 37880605
[TBL] [Abstract][Full Text] [Related]
10. Fluorescence in situ hybridization is superior for monitoring Epstein Barr viral load in infectious mononucleosis patients.
Cao P; Zhang M; Wang W; Dai Y; Sai B; Sun J; Wang L; Wang F; Li G; Xiang J
BMC Infect Dis; 2017 May; 17(1):323. PubMed ID: 28468603
[TBL] [Abstract][Full Text] [Related]
11. Comparison of plasma proteomic profiles of patients with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis and infectious mononucleosis.
Haruta K; Suzuki T; Yamaguchi M; Fukuda Y; Torii Y; Takahashi Y; Ito Y; Kawada JI
J Med Virol; 2024 Feb; 96(2):e29450. PubMed ID: 38304956
[TBL] [Abstract][Full Text] [Related]
12. Analysis of prognostic risk factors in children with Epstein-Barr virus-associated hemophagocytic syndrome.
Xue H; Chen C; Li W; Lin C; Fang J; Li Y; Xu H
Minerva Pediatr; 2015 Jun; 67(3):251-61. PubMed ID: 25941132
[TBL] [Abstract][Full Text] [Related]
13. A case of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis with severe cardiac complications.
Kawamura Y; Miura H; Matsumoto Y; Uchida H; Kudo K; Hata T; Ito Y; Kimura H; Yoshikawa T
BMC Pediatr; 2016 Oct; 16(1):172. PubMed ID: 27793118
[TBL] [Abstract][Full Text] [Related]
14. Epidemiologic features of children with Epstein-Barr virus associated diseases in Hangzhou, China.
Shi J; Ma W; Li W
J Med Virol; 2020 Aug; 92(8):1277-1282. PubMed ID: 31750545
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children: report of the Japan Histiocytosis Study Group.
Kogawa K; Sato H; Asano T; Ohga S; Kudo K; Morimoto A; Ohta S; Wakiguchi H; Kanegane H; Oda M; Ishii E
Pediatr Blood Cancer; 2014 Jul; 61(7):1257-62. PubMed ID: 24535916
[TBL] [Abstract][Full Text] [Related]
16. Treatment choice of immunotherapy or further chemotherapy for Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
Shiraishi A; Ohga S; Doi T; Ishimura M; Takimoto T; Takada H; Miyamoto T; Abe Y; Hara T
Pediatr Blood Cancer; 2012 Aug; 59(2):265-70. PubMed ID: 22183955
[TBL] [Abstract][Full Text] [Related]
17. Profiling of EBV-Encoded microRNAs in EBV-Associated Hemophagocytic Lymphohistiocytosis.
Zhou C; Xie Z; Gao L; Liu C; Ai J; Zhang L; Shen K
Tohoku J Exp Med; 2015 Oct; 237(2):117-26. PubMed ID: 26423217
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis: a retrospective study of 78 pediatric cases in mainland of China.
Jin YK; Xie ZD; Yang S; Lu G; Shen KL
Chin Med J (Engl); 2010 Jun; 123(11):1426-30. PubMed ID: 20819601
[TBL] [Abstract][Full Text] [Related]
19. Factors predicting the recurrence of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children after treatment using the HLH-2004 protocol.
Yanagaisawa R; Matsuda K; Ohga S; Kanegane H; Morimoto A; Okamoto Y; Ohara A; Fukushima K; Sotomatsu M; Nomura K; Saito AM; Horibe K; Ishii E; Nakazawa Y
Int J Hematol; 2019 May; 109(5):612-617. PubMed ID: 30788725
[TBL] [Abstract][Full Text] [Related]
20. Cytokine profiles as novel diagnostic markers of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children.
Han XC; Ye Q; Zhang WY; Tang YM; Xu XJ; Zhang T
J Crit Care; 2017 Jun; 39():72-77. PubMed ID: 28222313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
